Market access: Unilever headquarters in Rotterdam. The latest deal with GlaxoSmithKline gives Unilever access to India’s malt-based hot drinks segment, estimated to be US1.1bil.— Reuters
GENEVA: Unilever has agreed to a merger with GlaxoSmithKline Plc’s Indian consumer-health unit for €3.3bil (US$3.8bil) in cash and shares of its India-listed unit as it seeks to boost its presence in the world’s fastest-growing major economy.
The purchase also includes an 82% stake in Glaxo’s Bangladesh unit and other commercial operations and assets outside India, according to the statement.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
